mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy-Reference-Cited by-同舟云学术

mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy

Published:2019-06 Issue:6 Volume:37 Page:352.e25-352.e30
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Gold Samuel A.^ORCID,VanderWeele David J.,Harmon Stephanie,Bloom Jonathan B.,Karzai Fatima,Hale Graham R.,Marhamati Shawn,Rayn Kareem N.,Mehralivand Sherif^ORCID,Merino Maria J.,Gulley James L.,Bilusic Marijo,Madan Ravi A.,Choyke Peter L.,Turkbey Baris,Dahut William,Pinto Peter A.

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference20 articles.

1. Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up;Merino;BMC Cancer,2013

2. Natural history of surgically treated high-risk prostate cancer;Briganti;Urol Oncol,2015

3. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results;Roehl;J Urol,2004

4. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up;Antonarakis;BJU Int,2012

5. Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer;Cha;Urol Oncol,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and Staging Intensification Strategies Associated with Radical Prostatectomy for High-Risk Prostate Cancer: Efficacy Evaluation and Exploration of Novel Approaches;Cancers;2024-07-05

2. Diagnostic efficacy and interobserver agreement among readers with variable experience of the Prostate Imaging for Recurrence Reporting system with whole-mount histology after androgen deprivation therapy as a reference;Quantitative Imaging in Medicine and Surgery;2024-04

3. The presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapy;Urologic Oncology: Seminars and Original Investigations;2024-03

4. Effect of Neoadjuvant Hormonal Therapy on the Postoperative Course for Patients Undergoing Robot-Assisted Radical Prostatectomy;Journal of Clinical Medicine;2023-04-22

5. Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review;Journal of Personalized Medicine;2023-04-07